Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies

This study traces the use of the anticancer drug capecitabine through its loss of patent protection to evaluate the effect of generic pricing on the cost of oral anticancer drugs.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Intern Med
Asıl Yazarlar: Cole, Ashley L., Sanoff, Hanna K., Dusetzina, Stacie B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2017
Konular:
Research Letter
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820701/
https://ncbi.nlm.nih.gov/pubmed/28892541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.2788
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller